C section News and Research

RSS

Brain cell transplants help replace degenerated neurons, finds Swiss research team

A Swiss research team has found that using an animal's own brain cells (autologous transplant) to replace degenerated neurons in select brain areas of donor primates with simulated but asymptomatic Parkinson's disease and previously in a motor cortex lesion model, provides a degree of brain protection and may be useful in repairing brain lesions and restoring function.

29 Oct 2009

Third quarter 2009 financial results announced by Omega Healthcare Investors

Omega Healthcare Investors, Inc. today announced its results of operations for the quarter ended September 30, 2009. The Company also reported Funds From Operations (“FFO”) available to common stockholders for the three months ended September 30, 2009 of $30.0 million or $0.36 per common share.

29 Oct 2009

WHO identifies five major causes of premature death

Targeting the five major causes of premature death could increase global life expectancy by almost five years, the WHO said Tuesday, Reuters reports. According to a WHO's Global Health Risks report, which looked at 24 major health risks, "[p]oor childhood nutrition, unsafe sex, alcohol, bad sanitation and hygiene, and high blood pressure are to blame for around a quarter of the 60 million premature deaths around the world each year," the news service writes.

28 Oct 2009

Auxilium Pharmaceuticals reports increased net revenues of $42.1 million in third quarter 2009

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended September 30, 2009. For the third quarter of 2009, Auxilium reported net revenues of $42.1 million compared to net revenues of $32.6 million in the third quarter of 2008.

28 Oct 2009

Provisions in health care bill may transform nation's largest abortion chain into quasi-government status

The Senate version of America's Healthy Future Act of 2009 may transform the nation's largest abortion chain into a quasi-government entity for sex education.

28 Oct 2009

Spectranetics announces financial results for third quarter 2009

Spectranetics Corporation today reported financial results for the quarter and nine months ended September 30, 2009.

28 Oct 2009

Catheter-directed therapy safe and effective for treating acute pulmonary embolism

William Kuo, MD, was the on-call interventional radiologist one Friday night three years ago when he received a call from the intensive care unit at Stanford Hospital & Clinics. He was asked to attend to a 62-year-old woman who had collapsed at home and was rushed to the emergency room with massive blood clots in her lungs.

28 Oct 2009

Quebec City to host Conference of the Canadian Association of Wound Care

Quebec City this week hosts of one of Canada's largest health care conferences, as over 1,000 delegates meet at the annual Conference of the Canadian Association of Wound Care (CAWC).

27 Oct 2009

Life Technologies reports third quarter 2009 results; non-GAAP and organic revenues increase by 3% and 5%

Life Technologies Corporation (NASDAQ:LIFE) today announced results for its third quarter ended September 30, 2009. Non-GAAP revenue for the third quarter was $805 million, an increase of 3 percent over third quarter revenue of $784 million in 2008, as if Invitrogen and Applied Biosystems had been combined.

From Danaher 27 Oct 2009

LCA-Vision announces third quarter 2009 operational and financial results

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three and nine months ended September 30, 2009.

27 Oct 2009

OSI Systems announces financial results for the first quarter ended September 30, 2009

OSI Systems, Inc., a vertically integrated provider of specialized electronics, today announced financial results for the first quarter ended September 30, 2009.

27 Oct 2009

Dartmouth explores glucorticoid side effects on bladder-cancer patients

In her most recent study of possible triggers of cancer among northern New England residents, Dartmouth epidemiologist Margaret R. Karagas, Ph.D., and her team identified an enhanced risk to the bladders of patients taking drugs that suppress the immune system.

27 Oct 2009

New significant tool to improve the quality of care for patients with brain tumors released

While the nation is debating how best to reform healthcare, the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) announce a new significant tool to improve the quality of care for patients who suffer from brain tumors.

27 Oct 2009

Cadient Group in Deloitte's list of fastest growing companies in the Greater Philadelphia region

Cadient Group, the premier strategic interactive marketing agency serving the healthcare industry, today announced that it has been recognized as one of the fastest growing technology, life sciences and cleantech companies in the Greater Philadelphia region for the second consecutive year.

26 Oct 2009

HealthSouth announces credit agreement amendment and extended maturity of a portion of its term loan

HealthSouth Corporation today announced it has amended its credit agreement and extended maturity of a portion of its term loan. A segment of the lenders under the term loan that has a current outstanding balance of approximately $750 million will extend the maturity for $300 million of that loan from March 2013 to September 2015, contingent on certain conditions.

26 Oct 2009

Results from Phase I dose-escalation study of AT-101 announced

Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral, pan-Bcl-2 inhibitor, in patients with the most malignant type of brain tumor, were described in an oral presentation at the 2009 Joint Meeting of the Society for NeuroOncology (SNO) and AANS/CNS Section on Tumors in New Orleans, Louisiana (Concurrent Session VI: Radiation Oncology, October 23, 2009; Abstract # 449).

26 Oct 2009

HealthSouth to reimburse shareholder expenses for proxy solicitation campaign

HealthSouth Corporation today announced that its Board of Directors has authorized the Company to amend its bylaws to adopt procedures relating to shareholder nominations for the election of directors.

26 Oct 2009

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Antigenics today announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cancer) at the 2009 Joint Meeting of SNO (Society for Neuro-Oncology) and AANS/CNS Section on Tumors 2009 in New Orleans, LA.

26 Oct 2009

Novo Nordisk receives Good Design Award from Japan Industrial Design Promotion Organization

Novo Nordisk has been awarded a Good Design Award(TM) for NovoTwist(TM), the new needle designed for use with the insulin delivery device FlexPen(R). The needle, which has a simple 'just twist' attachment and detachment, makes injection easier for people with diabetes.

From Novo Nordisk 26 Oct 2009

Orthovita to present comparative study data of its Cortoss product to polymethylmethacrylate

Orthovita, Inc., an orthobiologics and biosurgery company, is pleased to announce that Dr. Pierce D. Nunley, Director of the Spine Institute of Louisiana, will present his abstract, “A Comparison of Clinical Outcomes and Adjacent Level Fractures in Patients Receiving Vertebroplasty for Osteoporotic Compression Fractures Using CortossTM or PMMA: A Prospective, Randomized Trial,” at the 2009 Annual Meeting of the Congress of Neurological Surgeons (CNS).

24 Oct 2009

C section News and Research

Brain cell transplants help replace degenerated neurons, finds Swiss research team

Third quarter 2009 financial results announced by Omega Healthcare Investors

WHO identifies five major causes of premature death

Auxilium Pharmaceuticals reports increased net revenues of $42.1 million in third quarter 2009

Provisions in health care bill may transform nation's largest abortion chain into quasi-government status

Spectranetics announces financial results for third quarter 2009

Catheter-directed therapy safe and effective for treating acute pulmonary embolism

Quebec City to host Conference of the Canadian Association of Wound Care

Life Technologies reports third quarter 2009 results; non-GAAP and organic revenues increase by 3% and 5%

LCA-Vision announces third quarter 2009 operational and financial results

OSI Systems announces financial results for the first quarter ended September 30, 2009

Dartmouth explores glucorticoid side effects on bladder-cancer patients

New significant tool to improve the quality of care for patients with brain tumors released

Cadient Group in Deloitte's list of fastest growing companies in the Greater Philadelphia region

HealthSouth announces credit agreement amendment and extended maturity of a portion of its term loan

Results from Phase I dose-escalation study of AT-101 announced

HealthSouth to reimburse shareholder expenses for proxy solicitation campaign

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Novo Nordisk receives Good Design Award from Japan Industrial Design Promotion Organization

Orthovita to present comparative study data of its Cortoss product to polymethylmethacrylate

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News